Project Grant HT94252510025
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$434K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...
This $434,499.00 federal Project Grant award from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) supports the restoration of alveolar type II cell function in emphysema. The award was granted to Temple University-Of The Commonwealth System Of Higher Education, a prominent public research university in Philadelphia, Pennsylvania, to conduct this advanced biomedical research. The funding will be used for a 2-year period from September 1, 2025 to August...
This federal Project Grant award of $1,585,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Temple University to target lymphatic chemokine signaling and promote lymphangiogenesis for the treatment of lymphedema. The 4-year award, starting on March 1, 2025 and ending on February 28, 2029, will enable the university to conduct advanced biomedical research focused on transforming healthcare for military...
This $435,876 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports innovative biomedical research conducted by Temple University. The research project, titled "KIF11: A NOVEL THERAPEUTIC TARGET FOR LYMPHEDEMA," aims to explore a novel therapeutic target for the treatment of lymphedema, a chronic and debilitating condition. Through this three-year grant, which runs from March 1, 2025, to February...
The Defense Health Agency awarded Temple University a $1,999,996 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to identify diagnostic biomarkers of the cerebrovascular contributions to cognitive impairment in repeated blast concussion. The grant, awarded on June 1, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the public, with a performance period through May 31, 2029. This project...
The Defense Health Agency awarded Texas A&M University System Health Science Center a $303,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on Potential-Independent Mitochondrial Targeting from February 15, 2023 through August 31, 2025. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions. This award will allow the...
The Defense Health Agency awarded a $311,000 Project Grant to the University of Washington under the Military Medical Research and Development federal grant program (CFDA 12.420) to manage mitochondrial disorders through increased intestinal fermentation and reduced metabolic burden from January 1, 2023 to December 31, 2024. The University of Washington will deliver research to transform health care for service members and the public by investigating medical solutions for the battlefield through...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The Defense Health Agency awarded a $312,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct research on "Inhibiting Mitochondrial Permeability Transition Pore Opening to Treat Mitochondrial Myopathy" over the period of September 1, 2023 to August 31, 2025. This grant was provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to...